Envision Healthcare Corporation (NYSE:EVHC) saw some unusual options trading on Thursday. Investors bought 4,031 put options on the company. This represents an increase of Infinity compared to the typical volume of 0 put options.

Hedge funds have recently bought and sold shares of the stock. Commonwealth Bank of Australia lifted its stake in Envision Healthcare Corporation by 24.3% during the second quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after purchasing an additional 410 shares during the last quarter. LMR Partners LLP acquired a new position in Envision Healthcare Corporation during the second quarter worth approximately $205,000. OLD Mutual Customised Solutions Proprietary Ltd. increased its position in Envision Healthcare Corporation by 54.5% during the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 3,401 shares of the company’s stock worth $209,000 after buying an additional 1,200 shares during the period. Cutter & CO Brokerage Inc. increased its position in Envision Healthcare Corporation by 11.1% during the second quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock worth $230,000 after buying an additional 367 shares during the period. Finally, Flinton Capital Management LLC increased its position in Envision Healthcare Corporation by 18.7% during the second quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock worth $280,000 after buying an additional 704 shares during the period.

A number of brokerages recently commented on EVHC. Bank of America Corporation cut Envision Healthcare Corporation from a “buy” rating to a “neutral” rating and set a $32.00 target price for the company. in a report on Thursday. Stephens cut Envision Healthcare Corporation from an “overweight” rating to an “equal weight” rating and set a $32.00 price objective for the company. in a research note on Thursday. KeyCorp decreased their price objective on Envision Healthcare Corporation from $67.00 to $37.00 and set an “overweight” rating for the company in a research note on Thursday. Oppenheimer Holdings, Inc. decreased their price objective on Envision Healthcare Corporation from $77.00 to $40.00 and set an “outperform” rating for the company in a research note on Thursday. Finally, Robert W. Baird decreased their price objective on Envision Healthcare Corporation from $70.00 to $35.00 and set an “outperform” rating for the company in a research note on Friday. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $49.21.

Shares of Envision Healthcare Corporation (EVHC) opened at $27.04 on Friday. The firm has a market capitalization of $3,267.14, a P/E ratio of 8.35, a P/E/G ratio of 0.57 and a beta of 0.69. Envision Healthcare Corporation has a 52 week low of $26.56 and a 52 week high of $74.75. The company has a debt-to-equity ratio of 0.89, a quick ratio of 2.82 and a current ratio of 3.01.

Envision Healthcare Corporation (NYSE:EVHC) last posted its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.08). The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $2.03 billion. Envision Healthcare Corporation had a positive return on equity of 4.88% and a negative net margin of 6.39%. Envision Healthcare Corporation’s revenue for the quarter was up 142.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.13 EPS. analysts forecast that Envision Healthcare Corporation will post 3.12 EPS for the current year.

Envision Healthcare Corporation announced that its board has authorized a stock repurchase program on Monday, September 18th that allows the company to buyback $250.00 million in shares. This buyback authorization allows the company to reacquire up to 4.5% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

COPYRIGHT VIOLATION WARNING: “Stock Traders Purchase High Volume of Put Options on Envision Healthcare Corporation (EVHC)” was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another site, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this article can be read at https://www.americanbankingnews.com/2017/11/05/stock-traders-purchase-high-volume-of-put-options-on-envision-healthcare-corporation-evhc.html.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.